Stocks News

LAST PRICE
189.2900
TODAY'S CHANGE (%)
Trending Up2.0700 (1.1057%)

Bid / Lots
189.0000/ 6
Ask / Lots
189.5800/ 2
Open / Previous Close
186.7900 / 187.2200
Day Range
Low 185.3750
High 190.9600
52 Week Range
Low 183.3800
High 347.7225
Volume
213,344
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR), from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: ICLR
  
  NEW YORK, NY / ACCESSWIRE / November 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:ICLR) concerning possible violations of federal securities laws.
Yesterday
- Shareholder Rights Advocates at Levi & Korsinsky Investigate ICON Public Limited Company (ICLR) Regarding Possible Securities Fraud Violations, from 7:32AM ET on Monday Nov 18, 2024 by Dow Jones
  7:32AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: ICLR
  
  NEW YORK, NY / ACCESSWIRE / November 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:ICLR) concerning possible violations of federal securities laws.
Nov 15, 2024
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors, from 4:00PM ET on Friday Nov 15, 2024 by Dow Jones
  4:00PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ICLR
  
  Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
  LOS ANGELES--(BUSINESS WIRE)--November 15, 2024--
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors, from 12:52PM ET on Friday Nov 15, 2024 by Dow Jones
  12:52PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ICLR
  
  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
  BENSALEM, Pa.--(BUSINESS WIRE)--November 15, 2024--
- Lost Money on ICON Public Limited Company (ICLR)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky, from 11:01AM ET on Friday Nov 15, 2024 by Dow Jones
  11:01AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ICLR
  
  NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ:ICLR) concerning possible violations of federal securities laws.

Today
- DJ Incyte Down Over 10%, on Pace for Largest Percent Decrease Since April 2018 -- Data Talk, from 19 minutes ago by Dow Jones
  19 minutes ago by Dow Jones
  Companies Mentioned: INCY
- GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: GRFS
- DJ S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Berry Global Group Lead, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: INCY, USM, WMT, BERY, TPG, OS
- RBC Cuts Price Target on Incyte to $74 From $80, Keeps Sector Perform Rating, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: INCY
- Biogen, Partner Say Late-Stage Trial of Lupus Erythematosus Drug Candidate Met Primary Endpoint, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: BIIB
- Berenberg Initiates Moderna at Hold, With $42 Price Target, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: MRNA
- *DJ Moderna Started at Hold by Berenberg, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: MRNA
- Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: BIIB
Yesterday
- Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs, from 18 hours ago by Dow Jones
  18 hours ago by Dow Jones
  Companies Mentioned: INCY
- DJ Moderna Price Target Cut to $69.00/Share From $115.00 by Piper Sandler, from 22 hours ago by Dow Jones
  22 hours ago by Dow Jones
  Companies Mentioned: MRNA

ICON PLC
NASDAQ:ICLRUnited States

Search Criteria

Today

Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR), from 3 hours ago by Dow Jones

Yesterday

Shareholder Rights Advocates at Levi & Korsinsky Investigate ICON Public Limited Company (ICLR) Regarding Possible Securities Fraud Violations, from 7:32AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors, from 4:00PM ET on Friday Nov 15, 2024 by Dow Jones

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors, from 12:52PM ET on Friday Nov 15, 2024 by Dow Jones

Lost Money on ICON Public Limited Company (ICLR)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky, from 11:01AM ET on Friday Nov 15, 2024 by Dow Jones

Peers Headlines

Today

DJ Incyte Down Over 10%, on Pace for Largest Percent Decrease Since April 2018 -- Data Talk, from 19 minutes ago by Dow Jones

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus, from 2 hours ago by Dow Jones

DJ S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Berry Global Group Lead, from 3 hours ago by Dow Jones

RBC Cuts Price Target on Incyte to $74 From $80, Keeps Sector Perform Rating, from 4 hours ago by MT Newswires

Biogen, Partner Say Late-Stage Trial of Lupus Erythematosus Drug Candidate Met Primary Endpoint, from 5 hours ago by MT Newswires

Berenberg Initiates Moderna at Hold, With $42 Price Target, from 5 hours ago by MT Newswires

*DJ Moderna Started at Hold by Berenberg, from 9 hours ago by Dow Jones

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity, from 9 hours ago by Dow Jones

Yesterday

Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs, from 18 hours ago by Dow Jones

DJ Moderna Price Target Cut to $69.00/Share From $115.00 by Piper Sandler, from 22 hours ago by Dow Jones